- £113.22m
- £101.54m
- £32.16m
- 76
- 18
- 44
- 40
REG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Board Changes
AnnouncementREG - Diaceutics PLC - H1 2024 Results - Continued Performance & Growth
AnnouncementREG - Diaceutics PLC - Notice of Results & Presentations
AnnouncementREG - Diaceutics PLC - Appointment of Nominated Adviser and Broker
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Diaceutics Launches Enhanced Rare-Disease Offering
AnnouncementREG - Diaceutics PLC - Enterprise Partnership and Launch of PMx
AnnouncementREG - Diaceutics PLC - Presenting at Canaccord Genuity Growth Conference
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and TVR
AnnouncementREG - Diaceutics PLC - Issue of Share Options/PDMR Shareholdings
AnnouncementREG - Diaceutics PLC - Board Changes
AnnouncementREG - Diaceutics PLC - Revenue growth of 24% in H1 with 55% now recurring
AnnouncementREG - Diaceutics PLC - Senior Management Appointments
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights
AnnouncementREG - Diaceutics PLC - Result of AGM
AnnouncementRCS - Diaceutics PLC - "Precision Medicine in Oncology " Virtual Event
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of AGM and Posting of Annual Report
Announcement